The rate of atrial fibrillation was also higher in RSV patients, although it depended on preexisting heart conditions and ...

Professor Margie Danchin addresses declining childhood vaccination rates and vaccine hesitancy through trust-building ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine recommendation to include adults 50 and older who are at higher risk of severe illness.

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

The US Food and Drug Administration has approved a vaccine against the respiratory syncytial virus, or RSV, for adults 60 and older. This vaccine, called Arexvy, is made by the drug company GSK.

RSV vaccines aren't needed every year. Federal regulators recommend a single dose of RSV vaccine, so If you were vaccinated last year, you won't need another dose this year.

RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here's the latest data and information.